Annual Operating Profit
-$42.99 M
-$13.84 M-47.45%
December 31, 2023
Summary
- As of February 12, 2025, BLRX annual operating income is -$42.99 million, with the most recent change of -$13.84 million (-47.45%) on December 31, 2023.
- During the last 3 years, BLRX annual operating profit has fallen by -$20.07 million (-87.52%).
- BLRX annual operating profit is now -1260.94% below its all-time high of $3.70 million, reached on December 31, 2010.
Performance
BLRX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$5.39 M
+$386.00 K+6.69%
September 1, 2024
Summary
- As of February 12, 2025, BLRX quarterly operating income is -$5.39 million, with the most recent change of +$386.00 thousand (+6.69%) on September 1, 2024.
- Over the past year, BLRX quarterly operating profit has stayed the same.
- BLRX quarterly operating profit is now -125.66% below its all-time high of $20.99 million, reached on September 30, 2010.
Performance
BLRX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$27.85 M
+$6.97 M+20.02%
September 1, 2024
Summary
- As of February 12, 2025, BLRX TTM operating income is -$27.85 million, with the most recent change of +$6.97 million (+20.02%) on September 1, 2024.
- Over the past year, BLRX TTM operating profit has stayed the same.
- BLRX TTM operating profit is now -405.54% below its all-time high of $9.11 million, reached on September 30, 2010.
Performance
BLRX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
BLRX Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -47.5% | 0.0% | 0.0% |
| 3 y3 years | -87.5% | 0.0% | 0.0% |
| 5 y5 years | -67.9% | 0.0% | 0.0% |
BLRX Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -73.5% | at low | -11.7% | +56.4% | -12.4% | +35.2% |
| 5 y | 5-year | -87.5% | at low | -15.9% | +56.4% | -29.3% | +35.2% |
| alltime | all time | -1260.9% | at low | -125.7% | +56.4% | -405.5% | +35.2% |
BioLineRx Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$5.39 M(-6.7%) | -$27.85 M(-20.0%) |
| Jun 2024 | - | -$5.77 M(+19.7%) | -$34.82 M(-10.6%) |
| Mar 2024 | - | -$4.82 M(-59.4%) | -$38.96 M(-9.4%) |
| Dec 2023 | -$42.99 M(+47.5%) | -$11.86 M(-4.0%) | -$42.99 M(+8.8%) |
| Sep 2023 | - | -$12.36 M(+24.6%) | -$39.53 M(+15.4%) |
| Jun 2023 | - | -$9.91 M(+12.0%) | -$34.25 M(+7.2%) |
| Mar 2023 | - | -$8.86 M(+5.5%) | -$31.93 M(+9.5%) |
| Dec 2022 | -$29.16 M(+17.7%) | -$8.40 M(+18.6%) | -$29.16 M(+6.6%) |
| Sep 2022 | - | -$7.08 M(-6.9%) | -$27.36 M(+3.2%) |
| Jun 2022 | - | -$7.60 M(+25.1%) | -$26.50 M(+4.3%) |
| Mar 2022 | - | -$6.08 M(-7.9%) | -$25.41 M(+2.5%) |
| Dec 2021 | -$24.78 M(+8.1%) | -$6.60 M(+6.1%) | -$24.78 M(+3.0%) |
| Sep 2021 | - | -$6.22 M(-4.5%) | -$24.05 M(+7.0%) |
| Jun 2021 | - | -$6.51 M(+19.5%) | -$22.48 M(+4.4%) |
| Mar 2021 | - | -$5.45 M(-7.2%) | -$21.54 M(-6.1%) |
| Dec 2020 | -$22.93 M(-18.4%) | -$5.87 M(+26.3%) | -$22.93 M(-13.4%) |
| Sep 2020 | - | -$4.65 M(-16.5%) | -$26.47 M(-7.0%) |
| Jun 2020 | - | -$5.57 M(-18.6%) | -$28.46 M(-3.1%) |
| Mar 2020 | - | -$6.84 M(-27.3%) | -$29.37 M(+4.5%) |
| Dec 2019 | -$28.11 M(+9.8%) | -$9.41 M(+41.7%) | -$28.11 M(+9.2%) |
| Sep 2019 | - | -$6.64 M(+2.6%) | -$25.73 M(+1.7%) |
| Jun 2019 | - | -$6.48 M(+16.1%) | -$25.30 M(+3.1%) |
| Mar 2019 | - | -$5.58 M(-20.7%) | -$24.55 M(-4.1%) |
| Dec 2018 | -$25.61 M(+1.4%) | -$7.04 M(+13.3%) | -$25.61 M(-2.5%) |
| Sep 2018 | - | -$6.21 M(+8.5%) | -$26.26 M(-3.1%) |
| Jun 2018 | - | -$5.73 M(-13.6%) | -$27.10 M(+2.0%) |
| Mar 2018 | - | -$6.63 M(-13.8%) | -$26.57 M(+5.3%) |
| Dec 2017 | -$25.24 M | -$7.69 M(+8.9%) | -$25.24 M(+15.1%) |
| Sep 2017 | - | -$7.06 M(+35.9%) | -$21.94 M(+13.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | - | -$5.19 M(-2.0%) | -$19.37 M(+7.4%) |
| Mar 2017 | - | -$5.30 M(+20.9%) | -$18.04 M(+9.2%) |
| Dec 2016 | -$16.51 M(+2.0%) | -$4.38 M(-2.3%) | -$16.51 M(+1.7%) |
| Sep 2016 | - | -$4.49 M(+16.1%) | -$16.23 M(+5.8%) |
| Jun 2016 | - | -$3.87 M(+2.4%) | -$15.35 M(-1.9%) |
| Mar 2016 | - | -$3.78 M(-7.9%) | -$15.64 M(-3.4%) |
| Dec 2015 | -$16.20 M(-6.1%) | -$4.10 M(+13.8%) | -$16.20 M(-6.3%) |
| Sep 2015 | - | -$3.60 M(-13.5%) | -$17.29 M(-2.6%) |
| Jun 2015 | - | -$4.17 M(-3.7%) | -$17.76 M(+1.5%) |
| Mar 2015 | - | -$4.33 M(-16.7%) | -$17.51 M(+1.5%) |
| Dec 2014 | -$17.25 M(+1.5%) | -$5.20 M(+27.7%) | -$17.25 M(+19.2%) |
| Sep 2014 | - | -$4.07 M(+4.1%) | -$14.47 M(+6.0%) |
| Jun 2014 | - | -$3.91 M(-4.0%) | -$13.65 M(-4.8%) |
| Mar 2014 | - | -$4.08 M(+68.9%) | -$14.33 M(-14.5%) |
| Dec 2013 | -$17.01 M(-22.1%) | -$2.41 M(-25.7%) | -$16.75 M(-21.5%) |
| Sep 2013 | - | -$3.25 M(-29.3%) | -$21.32 M(-7.5%) |
| Jun 2013 | - | -$4.59 M(-29.3%) | -$23.05 M(-2.1%) |
| Mar 2013 | - | -$6.50 M(-7.0%) | -$23.55 M(+6.3%) |
| Dec 2012 | -$21.83 M(+41.7%) | -$6.99 M(+40.5%) | -$22.15 M(+14.5%) |
| Sep 2012 | - | -$4.97 M(-2.2%) | -$19.36 M(+2.5%) |
| Jun 2012 | - | -$5.09 M(-0.4%) | -$18.89 M(+3.8%) |
| Mar 2012 | - | -$5.11 M(+21.9%) | -$18.21 M(+14.0%) |
| Dec 2011 | -$15.41 M(-516.1%) | -$4.19 M(-7.1%) | -$15.97 M(-4.1%) |
| Sep 2011 | - | -$4.51 M(+2.4%) | -$16.66 M(-288.4%) |
| Jun 2011 | - | -$4.40 M(+53.3%) | $8.84 M(+66.6%) |
| Mar 2011 | - | -$2.87 M(-41.1%) | $5.31 M(+25.2%) |
| Dec 2010 | $3.70 M | -$4.88 M(-123.2%) | $4.24 M(-53.5%) |
| Sep 2010 | - | $20.99 M(-364.5%) | $9.11 M(-176.7%) |
| Jun 2010 | - | -$7.94 M(+101.4%) | -$11.88 M(+201.4%) |
| Mar 2010 | - | -$3.94 M | -$3.94 M |
FAQ
- What is BioLineRx annual operating income?
- What is the all time high annual operating profit for BioLineRx?
- What is BioLineRx annual operating profit year-on-year change?
- What is BioLineRx quarterly operating income?
- What is the all time high quarterly operating profit for BioLineRx?
- What is BioLineRx quarterly operating profit year-on-year change?
- What is BioLineRx TTM operating income?
- What is the all time high TTM operating profit for BioLineRx?
- What is BioLineRx TTM operating profit year-on-year change?
What is BioLineRx annual operating income?
The current annual operating profit of BLRX is -$42.99 M
What is the all time high annual operating profit for BioLineRx?
BioLineRx all-time high annual operating income is $3.70 M
What is BioLineRx annual operating profit year-on-year change?
Over the past year, BLRX annual operating income has changed by -$13.84 M (-47.45%)
What is BioLineRx quarterly operating income?
The current quarterly operating profit of BLRX is -$5.39 M
What is the all time high quarterly operating profit for BioLineRx?
BioLineRx all-time high quarterly operating income is $20.99 M
What is BioLineRx quarterly operating profit year-on-year change?
Over the past year, BLRX quarterly operating income has changed by $0.00 (0.00%)
What is BioLineRx TTM operating income?
The current TTM operating profit of BLRX is -$27.85 M
What is the all time high TTM operating profit for BioLineRx?
BioLineRx all-time high TTM operating income is $9.11 M
What is BioLineRx TTM operating profit year-on-year change?
Over the past year, BLRX TTM operating income has changed by $0.00 (0.00%)